INS and diabetes mellitus: The DIGAMI trial is a prospective randomized control trial involving coronary care units of 19 Swedish hospitals, that first established a mortality benefit of intensive blood glucose control with insulin on the outcome of patients with diabetes suffering AMI (Malmberg et al., 1995).